beta-Alanyl-3-methyl-L-histidine nitrate (1:1)(CAS: 10030-52-1)

Beta-Alanyl-3-methyl-L-histidine nitrate (1:1) (CAS: 10030-52-1) is regulated under the Globally Harmonized System (GHS) for classification and labeling, and must comply with REACH regulations in the European Union. In the United States, it is also subject to FDA and EPA requirements for handling and disposal. Proper documentation and adherence to local and international regulations are essential for the safe handling and use of this compound.

While beta-Alanyl-3-methyl-L-histidine nitrate (1:1) (CAS: 10030-52-1) is a specialized compound, its synthetic alternatives include other histidine derivatives and related nitrate compounds. Common alternatives may include 3-methyl-L-histidine or similar amino acid derivatives, which can be used as precursors or substitutes in certain applications, depending on the specific research or industrial needs.

The market and research trends for beta-Alanyl-3-methyl-L-histidine nitrate (1:1) (CAS: 10030-52-1) are closely tied to its use in specialized pharmaceuticals and nutraceuticals. Current research focuses on its potential bioavailability and health benefits, particularly in muscle recovery and performance enhancement. Market demand is expected to grow as more studies validate its therapeutic applications.

Waste containing beta-Alanyl-3-methyl-L-histidine nitrate (1:1) (CAS: 10030-52-1) should be collected in appropriate containers and stored under controlled conditions to prevent contamination. Proper incineration or professional waste disposal services should be utilized, adhering to local environmental regulations. Ensure to follow all safety guidelines and maintain documentation of waste management practices to comply with regulatory requirements.